Total raised
$19.5M
Last: Series B 2018-07
Stage
Acquired
Founded
2011
Headcount
109
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Vectorious Medical Technologies has developed an in-heart microcomputer that monitors the heart's left atrium pressure, enabling optimal treatment of heart disease patients. Vectorious's V-LAP sensory implant is a digital, wireless, battery-less device that is able to communicate from deep within the body. It provides actionable feedback based on high-resolution waveform morphology from the heart's left atrium. In November 2020, the company was granted a breakthrough device designation for its left atrial pressure monitoring device.
Funding history · 3 rounds · $19.5M total
2018-07
Series B
$2.0M
2018-03
Series B
$10.0M
2015-02
Series A
$5.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
Semiconductors & ElectronicsChipsetsSensingMaterials & SubstancesImplantsData StorageCloudArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
minimally-invasiveheart-failuremedical-devicescardiologydiagnosticssensorsremote-monitoringpatientshospitalswireless-controlartificial-intelligencehealthcare-providershome-caredigital-healthcaredecision-supportcloud